Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Cabot Oil & Gas ( COG - Analyst Report ) has entered into a sales agreement, worth $250 million, with the U.S. arm of Japanese energy firm Osaka Gas Co., Ltd.
Per the deal, Cabot will sell a 35% non-operated working stake in Pearsall Shale acreage to Osaka. The interest covers approximately 50,000 net acres leased by Cabot in Atascosa, Frio, La Salle and Zavala counties of Texas.
Osaka will make a cash payment of $125 million to Cabot at closing, which is expected to take place on June 26. Osaka will pay the remaining $125 million, covering 85% of Cabot's future drilling costs in the Pearsall Shale.
The companies target to fully utilize the drilling expenses by the end of 2013. The initial plans include operations by two rigs, starting in July 2012. Cabot will add a third rig in 2013, followed by another in 2014.
Cabot management remains highly upbeat about this alliance that is expected to reap long-term benefits. Cabot believes that the developed Pearsall Shale will acts as a strong catalyst for growth in the coming years.
Houston, Texas based Cabot is an independent oil and gas exploration company with producing properties mainly in the U.S. As of year-end 2011, the company had 3.03 trillion cubic feet equivalent in proved reserves (96% natural gas). Cabot produced 187.5 billion cubic feet equivalent of oil and gas in 2011, of which more than 95% was natural gas.
We believe that Cabot has a diversified asset portfolio spanning between low-risk/long reserve-life Appalachian assets and large-volume/rapid-payout Gulf Coast properties, with further variety from large prospect inventories in the Rocky Mountains and the Anadarko Basin that have a broad mix of production and payout profiles.
However, we remain concerned given the weak fundamentals of natural gas and Cabot’s high exposure to the commodity. The company also faces competition from larger rivals such as Anadarko Petroleum Corporation ( APC - Analyst Report ) and Chevron Corporation ( CVX - Analyst Report ) . Hence, we maintain a long-term Neutral recommendation on the stock.
Cabot currently retains a Zacks #3 Rank, which translates into short-term Hold rating for a period of one to three months.
Read the full reports :
Analyst Report on COG
Analyst Report on CVX
Analyst Report on APC